Symptom på svininfluensan är generellt ganska lindriga och symptomen påminner i princip om vanlig influensa. Några vanliga svin influensa symptom är:
- Feber och frossa
- Hosta och halsont
- Värk i kroppen och huvudet
- Diarré och Ibland kräkningar
- Trötthet och förkylning
- Andningssvårigheter
Symptom svininfluensa


Lite intressant ändå att Chugai's VD redan långt före utbrottet förutspår en ökad försäljning av vaccinet med över 500 %.
Lite intressant också att de första fallen inträffar i en av världens mest tätbefolkade städer, Mexico City.
http://www.chugai-pharm.co.jp/pdf/annual_report/2009/eAR2009_12_04.pdf
CHUGAI PHARMACEUTICAL CO., LTD. ANNUAL REPORT 2008
2008
The biggest factor for the decline in revenues was the
fall in sales of the anti-influenza agent Tamiflu (down
¥30.3 billion, a decrease of 78.3%).
2009
"For the year, we forecast sales of Tamiflu to reach ¥53.0
billion, up 531.0%, due to expected resumption of government
stockpiling in FY2009 and the ongoing recovery
of the prescription rate for seasonal influenza."
Ovanstående årsrapport från 2009-12-04. (3-4 mån fore de första rapporterade fallen)
----------------------------------------
Akio Fukuda, Ph.D., Deputy Senior Manager, Corporate Planning Office
Chugai Pharmaceutical
Keiji Fukuda, the Geneva-based WHO’s assistant director-general for health security and environment
----------------------------------------
http://www.in-pharmatechnologist.com/Processing-QC/Japan-s-Tamiflu-suppl...
Rapporter om ökad själmordsbenägenhet bland underåriga vaccinerade
med Tamiflu gör att Japan halverar sitt lager av vaccinet.
05-Nov-2007
........................................
http://www.bloomberg.com/apps/news?pid=20601091&sid=aqQqGCANvyik&refer=i...
Chugai Pharmaceutical, a unit of Roche Holding AG and a seller of
Tamiflu, surged 14 percent to 1,845 yen, its largest gain since
January 2000.
Yuhan, the biggest South Korean drugmaker by market value,
soared by the 15 percent daily limit to 211,500 won, the biggest gainer
on the MSCI regional health- care index. The company was chosen
in 2006 to supply Roche Holding AG with a key ingredient to make
Tamiflu.
..
http://www.bloomberg.com/apps/news?pid=20601091&sid=aqQqGCANvyik&refer=i...
Growing concern about swine flu may put Roche and GlaxoSmithKline at the center of the action.
Roche makes Tamiflu, known generically as oseltamivir, and Glaxo makes Relenza, known generically as zanamavir. For a primer on these prescription antiviral drugs, take a look at our Q&A on swine flu. They may cut the severity and duration of the disease, though most of the patients who contracted swine flu in the U.S. have recovered without taking them. They’ve also been approved to reduce the risk of contracting the seasonal flu, though they don’t provide long-lasting protection.
Roche spokeswoman Martina Rupp told Dow Jones Newswires that the company has the key ingredients in place to quickly ramp up production of Tamiflu. She said the company so far hasn’t yet received any new big orders for the drug, adding that the number of orders will depend on how the World Health Organization classifies the outbreak.
Tamiflu’s fortunes in the past have risen and fallen amid fears about global flu pandemic. Roche had ramped up production of the drugs a few years back when fears about avian flu were rising. But sales of the drug were down recently as those concerns subsided.
http://sis.windhover.com/buy/abstract.php?id=2003600152&PHPSESSID=ajivah...
roche’s tillväxt från köpta bolag och patent
Sinovac Biotech Co – SARS